Relay Therapeutics logo

Relay Therapeutics share price today

(RLAY)

Relay Therapeutics share price is $4.58 & ₹393.01 as on 7 Jan 2025, 2.30 'hrs' IST

$4.58

0.16

(3.62%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Relay Therapeutics share price in Dollar and Rupees. Guide to invest in Relay Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Relay Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Relay Therapeutics share price movements

  • Today's Low: $4.41
    Today's High: $4.65

    Day's Volatility :5.16%

  • 52 Weeks Low: $4.01
    52 Weeks High: $12.14

    52 Weeks Volatility :66.97%

Relay Therapeutics Returns

PeriodRelay Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-29.28%
-8.4%
0.0%
6 Months
-36.31%
-3.8%
0.0%
1 Year
-63.38%
-0.1%
0.0%
3 Years
-83.6%
2.9%
-19.8%

Relay Therapeutics Key Statistics

in dollars & INR

Previous Close
$4.42
Open
$4.44
Today's High
$4.65
Today's Low
$4.41
Market Capitalization
$689.6M
Today's Volume
$1.1M
52 Week High
$12.14
52 Week Low
$4.01
Revenue TTM
$10.0M
EBITDA
$-389.5M
Earnings Per Share (EPS)
$-2.61
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.69%

How to invest in Relay Therapeutics from India?

It is very easy for Indian residents to invest directly in Relay Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Relay Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Relay Therapeutics or RLAY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Relay Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Relay Therapeutics shares which would translate to 0.187 fractional shares of Relay Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Relay Therapeutics, in just a few clicks!

Returns in Relay Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Relay Therapeutics investment value today

Current value as on today

₹41,168

Returns

₹58,832

(-58.83%)

Returns from Relay Therapeutics Stock

₹62,055 (-62.05%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Relay Therapeutics

160%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Relay Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 160% more investors are searching Relay Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Relay Therapeutics

  • SB INVESTMENT ADVISERS (UK) LTD

    16.67%

  • Vanguard Group Inc

    8.64%

  • BlackRock Inc

    6.30%

  • Casdin Capital, LLC

    5.53%

  • Bellevue Group AG

    4.41%

  • JPMorgan Chase & Co

    3.30%

Analyst Recommendation on Relay Therapeutics

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Relay Therapeutics(by analysts ranked 0 to 5 stars)

Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Relay Therapeutics

What analysts predicted

Upside of 368.44%

Current:

$4.58

Target:

$21.45

Insights on Relay Therapeutics

  • Price Movement

    In the last 3 months, RLAY stock has moved down by -32.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -1.0K → 10.00M (in $), with an average increase of 100.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -92.21M → -88.10M (in $), with an average increase of 4.7% per quarter
  • RLAY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 85.3%
  • RLAY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 139.3%
  • Price to Sales

    ForRLAY every $1 of sales, investors are willing to pay $58.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Relay Therapeutics Technicals Summary

Sell

Neutral

Buy

Relay Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Relay Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Relay Therapeutics Inc
-5.96%
-36.31%
-63.38%
-83.6%
-87.39%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Relay Therapeutics Inc
NA
NA
NA
-2.47
-0.43
-0.27
NA
5.03
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Relay Therapeutics Inc
Buy
$689.6M
-87.39%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Relay Therapeutics

relay therapeutics is building the world’s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. by placing protein motion at the heart of drug discovery, relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. headquartered in cambridge, mass., relay therapeutics is a private company launched in 2016. to date, relay therapeutics has raised $120m in financing from third rock ventures, bvf partners, gv (formerly google ventures), an affiliate of d.e. shaw research, casdin capital, ecor1 capital, section 32 and alexandria venture investments. our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. if you're creative, collaborative and passionate
Organization
Relay Therapeutics
Employees
294
CEO
Mr. Alexis A. Borisy A.M.
Industry
Health Technology

Management People of Relay Therapeutics

NameTitle
Mr. Alexis A. Borisy A.M.
Co-Founder & Independent Chairman
Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
CEO, President & Director
Dr. Mark Murcko Ph.D.
Co-Founder & Director
Mr. Thomas Catinazzo
Chief Financial Officer
Mr. Brian R. Adams J.D.
Chief Legal Officer & Secretary
Mr. Peter Rahmer
Chief Corporate Development Officer
Dr. Donald A. Bergstrom M.D., Ph.D.
President of Research & Development
Ms. Dorothee Kern Ph.D.
Founder
Dr. David Elliot Shaw Ph.D.
Founder
Mr. Matthew P. Jacobson Ph.D.
Founder

Important FAQs about investing in Relay Therapeutics from India :

What is Relay Therapeutics share price today?

Relay Therapeutics share price today stands at $4.58, Open: $4.44 ; Previous Close: $4.42 ; High: $4.65 ; Low: $4.41 ; 52 Week High: $12.14 ; 52 Week Low: $4.01. The stock opens at $4.44, after a previous close of $4.42. The stock reached a daily high of $4.65 and a low of $4.41, with a 52-week high of $12.14 and a 52-week low of $4.01.

Can Indians buy Relay Therapeutics shares?

Yes, Indians can invest in the Relay Therapeutics (RLAY) from India.

With INDmoney, you can buy Relay Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Relay Therapeutics at zero transaction cost.

How can I buy Relay Therapeutics shares from India?

It is very easy to buy Relay Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Relay Therapeutics be purchased?

Yes, you can buy fractional shares of Relay Therapeutics with INDmoney app.

What are the documents required to start investing in Relay Therapeutics stocks?

To start investing in Relay Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Relay Therapeutics

Today’s highest price of Relay Therapeutics (RLAY) is $4.65.

Today’s lowest price of Relay Therapeutics (RLAY) is $4.41.

What is today's market capitalisation of Relay Therapeutics

Today's market capitalisation of Relay Therapeutics RLAY is 689.6M

What is the 52 Week High and Low Range of Relay Therapeutics

  • 52 Week High

    $12.14

  • 52 Week Low

    $4.01

What are the historical returns of Relay Therapeutics?

  • 1 Month Returns

    -5.96%

  • 3 Months Returns

    -36.31%

  • 1 Year Returns

    -63.38%

  • 5 Years Returns

    -87.39%

Who is the Chief Executive Officer (CEO) of Relay Therapeutics

Mr. Alexis A. Borisy A.M. is the current Chief Executive Officer (CEO) of Relay Therapeutics.